ADHD medicine not safe and sound for kids Relating to a panel of professionals advising the U.S Click to see more . Meals and Medication Administration , the medication Provigil, although effective in treating attention deficit hyperactivity disorder in children and teenagers, is not safe enough to win authorization. The experts state they are most worried about the risk of pores and skin rashes that can lead to hospitalization and also have called on the drugmaker Cephalon to conduct more clinical trials. Panel chairman Wayne Goodman, a psychiatrist at the University of Florida, believes more patients have to be studied before authorization is granted.
Ongoing research are evaluating whether the compound can improve the cognitive deficits in the Alzheimer’s mouse model. ‘We have become thinking about the potential of MSDC’s substance for Alzheimer’s disease,’ stated Howard Fillit, MD, ADDF’s executive director. ‘Our relationship is usually another demonstration that venture philanthropy money can offer a critical catalyst for innovative drug discovery analysis conducted by biotechnology companies such as MSDC.’ Earlier this year, MSDC reported that a Phase IIa medical trial in type 2 diabetics showed that MSDC-0160 can improve insulin response and lower glucose in individuals with type 2 diabetes without producing the weight gain seen with currently marketed PPAR-activating insulin sensitizers.